C. Goulding et al., Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition, EUR J GASTR, 13(5), 2001, pp. 507-511
Background Musculoskeletal complaints, dry eyes, fatigue and anxiety are co
mmon symptoms in patients with hepatitis C virus (HCV) infection, but there
are few controlled data evaluating this.
Aim To assess the prevalence of rheumatological disease, fatigue and anxiet
y in different groups of patients with chronic HCV infection.
Patients and methods Seventy-seven patients with HCV were evaluated. Of the
se, 49 (64%) had been infected via contaminated anti-D immunoglobulin, 25 (
33%) were intravenous drug users (IVDUs), and three were transfusion relate
d; 78% were female. Twenty-five age- and sex-matched controls were also eva
luated. Assessment was performed by history, physical examination, the Fibr
omyalgia Impact Questionnaire (FIQ) and the Hospital Anxiety and Depression
Score (HADS).
Results Four (5%) patients fulfilled the criteria for fibromyalgia. All wer
e infected via anti-D immunoglobulin, and three were PCR positive. The mean
number of tender points in anti-D patients was 5.0 (+/- 4.07) compared wit
h 2.8 (+/- 2.7) in controls (P = 0.028) and 2.5 (+/- 2.2) in IVDUs (P < 0.0
04). There was no significant difference in the number of tender points bet
ween POP-positive and PCR-negative patients (P = 0.23). Anxiety and depress
ion scores were significantly higher in anti-D patients (P = 0.0001) and IV
DUs (P = 0.005) compared with controls. Forty per cent of the HCV patients
had a positive Schirmer test. Forty-two per cent of POP-positive patients h
ad a positive rheumatoid factor (RF, > 1/80).
Conclusion This study reveals a moderate increase in prevalence of fibromya
lgia in HCV patients. The number of tender points was related to mode of ac
quisition but not to PCR status. Anxiety and depression levels are also inc
reased in HCV patients compared with controls. Prevalence of RF was higher
in PCR-positive patients compared with controls and those who had cleared t
he virus. Eur J Gastroenterol Hepatol 13:507 - 511 (C) 2001 Lippincott Will
iams & Wilkins.